文献速递产科母胎医学

妊娠期高血压疾病的全基因组多基因风险评分也可预测长期心血管疾病风险

Genome-wide polygenic risk scores for hypertensive disease during pregnancy can also predict the risk for long-term cardiovascular disease.
PubMed 文献 · Am J Obstet Gynecol · 2023-03-16

在UK Biobank的164575名欧洲裔至少有一次活产的女性中,按妊娠期高血压疾病多基因风险评分分为低、中、高风险组,评估新发动脉粥样硬化性心血管疾病。高风险组相比低风险组,即使调整妊娠期高血压疾病史,新发动脉粥样硬化性心血管疾病风险仍升高,包括冠心病、心肌梗死和外周动脉疾病。

要点

  • 妊娠期高血压疾病高遗传风险与长期动脉粥样硬化性心血管疾病风险升高相关。
  • 高风险组在入组时高血压患病率更高。
  • 多基因风险评分对妊娠期高血压疾病预测长期心血管结局具有信息价值。

核心结论

  • 妊娠期高血压疾病高遗传风险与动脉粥样硬化性心血管疾病风险升高相关。
  • 本研究为妊娠期高血压疾病多基因风险评分预测长期心血管结局提供了信息价值证据。

研究设计与样本

  • 在UK Biobank参与者中,纳入至少有一次活产的欧洲裔女性(n=164575)。
  • 按妊娠期高血压疾病多基因风险评分分为低风险(评分≤第25百分位)、中风险(评分第25至75百分位)、高风险(评分>第75百分位)。
  • 评估新发动脉粥样硬化性心血管疾病,定义为冠心病、心肌梗死、缺血性卒中或外周动脉疾病的新发。

主要发现

  • 研究人群中2427人(1.5%)有妊娠期高血压疾病史,8942人(5.6%)在入组后发生新发动脉粥样硬化性心血管疾病。
  • 妊娠期高血压疾病高遗传风险女性在入组时高血压患病率更高。
  • 入组后,相比低遗传风险女性,高遗传风险女性新发动脉粥样硬化性心血管疾病风险升高,包括冠心病、心肌梗死和外周动脉疾病,即使调整妊娠期高血压疾病史后仍如此。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypertensive disorders during pregnancy are associated with the risk of long-term cardiovascular disease after pregnancy, but it has not yet been determined whether genetic predisposition for hypertensive disorders during pregnancy can predict the risk for long-term cardiovascular disease. OBJECTIVE: This study aimed to evaluate the risk for long-term atherosclerotic cardiovascular disease according to polygenic risk scores for hypertensive disorders during pregnancy. STUDY DESIGN: Among UK Biobank participants, we included European-descent women (n=164,575) with at least 1 live birth. Participants were divided according to genetic risk categorized by polygenic risk scores for hypertensive disorders during pregnancy (low risk, score ≤25th percentile; medium risk, score 25th∼75th percentile; high risk, score >75th percentile), and were evaluated for incident atherosclerotic cardiovascular disease, defined as the new occurrence of one of the following: coronary artery disease, myocardial infarction, ischemic stroke, or peripheral artery disease. RESULTS: Among the study population, 2427 (1.5%) had a history of hypertensive disorders during pregnancy, and 8942 (5.6%) developed incident atherosclerotic cardiovascular disease after enrollment. Women with high genetic risk for hypertensive disorders during pregnancy had a higher prevalence of hypertension at enrollment. After enrollment, women with high genetic risk for hypertensive disorders during pregnancy had an increased risk for incident atherosclerotic cardiovascular disease, including coronary artery disease, myocardial infarction, and peripheral artery disease, compared with those with low genetic risk, even after adjustment for history of hypertensive disorders during pregnancy. CONCLUSION: High genetic risk for hypertensive disorders during pregnancy was associated with increased risk for atherosclerotic cardiovascular disease. This study provides evidence on the informative value of polygenic risk scores for hypertensive disorders during pregnancy in prediction of long-term cardiovascular outcomes later in life.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Lee SM, Shivakumar M, Xiao B, et al. Genome-wide polygenic risk scores for hypertensive disease during pregnancy can also predict the risk for long-term cardiovascular disease. Am J Obstet Gynecol. 2023. PMID: 36933686. doi:10.1016/j.ajog.2023.03.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。